By Gregory M. Vercellotti, MD
2009-07-01
Dr. Vercellotti indicated no relevant conflicts of interest.
Mayer DC, Cofie J, Jiang L et al. Glycophorin B is the erythrocyte receptor of Plasmodium falciparum erythrocyte-binding ligand, EBL-1. Pro Natl Acad Sci USA. 2009;106:5348-52.
This year is the bicentennial of the birth of Charles Darwin and the sesquicentennial of the publication of On the Origin of Species. For
thousands of years the principles of evolution have been played out in
the minuet between the malaria parasite and the red blood cell.
Survival of the human species has depended upon genetic resistance to
malaria across the globe. Evolutionary anti-malarial strategies have
included inhibition of intracellular growth, release of mature
merozoites or entry into the red cell, promotion of phagocytosis and
immune clearance of infected cells, and prevention of vascular or blood
cell adherence of infected red cells. Selective pressure has led to
high frequencies of otherwise rare RBC genes in certain populations in
Africa, Southeast Asia, the Mediterranean, and elsewhere that lessen
malarial morbidity and mortality.1 For example,
hemoglobinopathies, including S, C, E, and thalassemia; metabolic
abnormalities, such as glucose-6-phosphate dehydrogenase deficiency;
cytoskeletal membrane defects like ovalocytosis or elliptocytosis; and
red cell surface antigens, such as the Duffy blood group system,
glycophorins, ABO molecules, and complement receptors, all have been
linked to genetic resistance to malaria.2,3,4
 |
| Click image to enlarge |
The life cycle of the Plasmodium falciparum malarial
parasite begins when the anopheles mosquito injects sporozoites into a
human. These go to the liver where a mature schizont eventually
ruptures merozoites into the blood stream where they invade uninfected
erythrocytes to begin the erythrocytic phase of infection. Infected
erythrocyte schizonts can also release merozoites (see Figure).
Erythrocyte invasion depends on ligands on the merozoite and host
receptors on the erythrocyte membrane. An example is the Duffy blood
group system and its role in determining susceptibility to Plasmodium vivax infection. Duffy-negative erythrocytes resist invasion of Plasmodium vivax merozoites, and Duffy-negative individuals are hence resistant to infection if exposed to mosquitos infected with Plasmodium vivax.5
Plasmodium falciparum has a family of genes encoding erythrocyte-binding proteins related to the Duffy-binding proteins of vivax.
Several of these have been shown to bind to glycophorins A and C on
erythrocytes, but the erythrocyte receptor for one, EBL-1, was not
known. Mayer et al., from Louis Miller’s group at Virginia
Commonwealth, have now shown that EBL-1 binds glycophorin B.They first
showed, by confocal microscopy, that EBL-1 was localized on a Plasmodium falciparum clone
Dd/Nm and that it was only expressed in the late schizont phase of
infection. EBL-1 could bind to erythrocytes, but this was blocked if
the erythrocytes were pre-treated with neuraminidase or chymotrypsin,
but not trypsin. The requirement for sialic acid for binding is a
characteristic of glycophorin B and indeed glycophorin B-null
erythrocytes did not bind EBL-1. When EBL-1 was expressed on CHO cells
they acquired capacity to bind glycophorin B+ but not glycophorin
B-null erythrocytes. Glycophorin B+ cells treated with neuraminidase
and chymotrypsin did not bind EBL-1-expressing CHO cells.
Thus, in this year of celebrating Darwin, it is exciting that another example of natural selection in the battle against Plasmodium falciparum malaria
has been discovered. This study gives further molecular basis to the
observations that Klebs and Tomassi-Crudeli made in 18886 in
regard to malaria resistance of those of African descent. The
glycophorin B gene has a high degree of polymorphism in
malaria-endemic areas, leading often to loss of expression; glycophorin
B deficiency is found in 59 percent of the Efe pygmies of the Ituri
Forest in the Democratic Republic of Congo, and the authors speculate
that it provides them resistance to infection. The elegant studies
outlined above provide robust evidence for this conjecture. These
lessons of natural selection provide insights for new therapies against
this world-wide scourge. Two hundred years after Darwin’s birth,
hematologists peer into the red blood cell to better understand the
balance of nature.
Miller LH. Malaria. Protective selective pressure. Nature.1996;383:480-1.
Weatherall DJ, Miller LH, Baruch DI et al. Malaria and the red cell. Hematology. ASH Educ Program. 2002;35-57.
Casals-Pascual C, Roberts DJ. Malaria and the red cell. Vox Sang. 2004;87:Suppl 2:115-9.
Roberts DJ, Williams TN. Haemoglobinopathies and resistance to malaria. Redox Rep. 2003;8:304-10.
Young MD, Mason SJ, Dvorak JA et al. Experimental testing of the immunity of Africans to Plasmodium vivax. J Parasitol.1955;41:315-21.
Roberts,
David J., Tyler Harris, and Thomas Williams. “The influence of
inherited traits on malaria infection.” Susceptibility to Infectious
Diseases: The Importance of Host Genetics. Ed. Richard John Bellamy.
Cambridge University Press, 2004. 139-84.
back to top